Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?
- 11 October 2001
- journal article
- clinical trial
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 29 (4), 323-327
- https://doi.org/10.1002/lsm.1124
Abstract
Background and Objective Polyhematoporphyrin (Photosan®) as sensitizers for photodynamic therapy (PDT) in advanced esophageal cancer carry the risk of prolonged photosensitivity of the skin. New sensitizers such as 5‐aminolaevulinic acid (ALA) with low rates of skin phototoxicity appear to be promising alternatives. The aim of this study was to evaluate the efficacy of ALA compared to Photosan® for PDT in advanced esophageal carcinoma regarding phototoxicity of the skin, reduction of dysphagia, tumor stenosis, and tumor length and Karnovsky performance status. Study Design/Materials and Methods After diagnostic work‐up, photosensitization was done in 22 patients with ALA (60 mg/kg body weight, oral, 6–8 hours prior to PDT) and in 27 patients with Photosan® (2 mg/kg body weight, i.v., 48 hours before PDT). The light dose was calculated as 300 J/cm fibre tip. Light at 630 nm was applied using a pumped dye laser. In both groups, additional hyperbaric oxygenation was applied at a level of 2 absolute atmospheric pressure. Results Improvement regarding dysphagia, stenosis diameter, and tumor length could be obtained in both treatment arms with a significant difference in favour of the Photosan®‐group, P = 0.02; P = 0.0000; and P = 0.000014, respectively. The Karnovsky performance status also improved in both groups and showed no significant difference (P = 0.12). The median survival time for the ALA‐group was 8.0 months, compared with 9.0 months for the Photosan® group. No sunburn or other major treatment related complication occurred in both treatment arms. Thirty‐day mortality was 0%. Conclusion Despite the limitations of a non‐randomized study, photosensitzation with Photosan® seems to be more effective in PDT of advanced esophageal carcinoma compared to ALA. Lasers Surg. Med. 29:323–327, 2001.Keywords
This publication has 20 references indexed in Scilit:
- Clinical Photodynamic Therapy: Where Is It Heading?Endoscopy, 1998
- Enhanced Effectiveness of Photodynamic Therapy with Laser Light Fractionation in Patients with Esophageal CancerEndoscopy, 1997
- Photodynamic therapy for esophageal malignancy: A prospective twelve-year studyThe Annals of Thoracic Surgery, 1996
- Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trialGastrointestinal Endoscopy, 1995
- Photodynamic therapy: Successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acidGastrointestinal Endoscopy, 1995
- Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.Gut, 1995
- Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude miceEuropean Journal of Cancer and Clinical Oncology, 1991
- Cutaneous phototoxic occurrences in patients receiving Photofrin®Lasers in Surgery and Medicine, 1990
- Photodynamic therapy for colorectal cancer: A quantitative pilot studyBritish Journal of Surgery, 1990
- Porphyrin and Haem Biosynthesis and its ControlActa Medica Scandinavica, 1966